Sales and Marketing

Showing 15 posts of 11527 posts found.

Mylan buys Abbott generics

July 15, 2014 Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan

Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …

UK digital health showcased in China

July 15, 2014 Medical Communications, Sales and Marketing China, Shanghai, UK, britain, comms, digital, health

The British government is showcasing its most promising digital health firms at a new centre in China. The “Healthcare is …

Baxter takes R&D head from Merck Serono

July 15, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, baxter, john orloff

Baxter International has appointed Dr John Orloff as its vice president and global head of R&D development for Baxter BioScience. …

Contraceptive microchip tipped to revolutionise birth control

July 14, 2014 Medical Communications, Sales and Marketing Bill Gates, MIT, contraceptive, device, implant, microchips

IT start-up company MicroCHIPS is developing a radical new contraceptive in the form of a microchip that is implanted under …

AbbVie a step closer to Shire takeover

July 14, 2014 Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

Roche combination drug for melanoma impresses

July 14, 2014 Research and Development, Sales and Marketing GSK, Roche, Yervoy, braf, mekinist. MEK, melanoma

Roche’s investigational melanoma drug cobimetinib has helped late-stage patients live longer when used in combination with its established skin cancer …

GSK investigator charged in China

July 14, 2014 Medical Communications, Sales and Marketing China, GSK, Witty, bribery, humphrey, sex tape

The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …

Working Life: Celgene’s Rob Moore

July 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Working Life, rob moore

How did you find your way into your current role? I joined the pharmaceutical industry almost 20 years ago with …

ProStrakan pays £230m for Archimedes

July 14, 2014 Sales and Marketing Archimedes, Cancer, ProStrakan, pain, pecfent

The ProStrakan Group is to looking to expand its offerings via a payment of £230 million for Archimedes Pharma. The …

Two hires at Cello Health Communications

July 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, cello health, davies, yates

Healthcare comms agency Cello Health Communications has made two senior appointments at its London office. Anthea Davies (pictured) joins the …

Bayer in Oxford tie-up

July 11, 2014 Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university

Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …

BMS to make Opdivo submission

July 11, 2014 Sales and Marketing BMS, Cancer, EMA, FDA, ono, opdivo, pd-1

Bristol-Myers Squibb is to submit cancer treatment Opdivo to the US authorities after the drug received its first approval in …

QRxPharma announces several resignations

July 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, PACE, QRxPharma, farrell, quinn

Australian pharma development firm QRxPharma has confirmed that its chairman Dr Peter Farrell and director Dr Gary Pace have resigned. …

Servier fined €331m by European Commission

July 10, 2014 Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva

The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …

EMA delays trial transparency – again

July 10, 2014 Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency

The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
The Gateway to Local Adoption Series

Latest content